The SSX Family of Cancer-Testis Antigens as Target Proteins for Tumor Therapy

Cancer-testis antigens (CTAs) represent an expanding class of tumor-associated proteins defined on the basis of their tissue-restricted expression to testis or ovary germline cells and frequent ectopic expression in tumor tissue. The expression of CTA in MHC class I-deficient germline cells makes these proteins particularly attractive as immunotherapeutic targets because they serve as essentially tumor-specific antigens for MHC class I-restricted CD8+ T cells. Moreover, because CTAs are expressed in many types of cancer, any therapeutic developed to target these antigens might have efficacy for multiple cancer types. Of particular interest among CTAs is the synovial sarcoma X chromosome breakpoint (SSX) family of proteins, which includes ten highly homologous family members. Expression of SSX proteins in tumor tissues has been associated with advanced stages of disease and worse patient prognosis. Additionally, both humoral and cell-mediated immune responses to SSX proteins have been demonstrated in patients with tumors of varying histological origin, which indicates that natural immune responses can be spontaneously generated to these antigens in cancer patients. The current review will describe the history and identification of this family of proteins, as well as what is known of their function, expression in normal and malignant tissues, and immunogenicity.

• Publication year

  2010

• Venue

  Clinical and Developmental Immunology

• Publication date

  2010-10-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2010/150591PMID 20981248PMCID 2963798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunological, paracrine and endocrine aspects of testicular immune privilege.

  2011cited by this paper
• Monophosphoryl lipid A (MPL) as an adjuvant for anti-cancer vaccines: clinical results.

  2010cited by this paper
• Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer.

  2009cited by this paper
• Coexpression of major histocompatibility complex class II with chemokines and nuclear NFκB p50 in melanoma: a rational for their association with poor prognosis

  2009cited by this paper
• Cancer/testis (CT) antigens: Potential targets for immunotherapy

  2009influential reference
• Cancer-testis antigens: potential targets for cancer immunotherapy.

  2009cited by this paper
• Cloning , Expression , and Chromosomal Localization to llpl 2-13 of a Human LIM / HOMEOBOX Gene , hLim-1

  2009cited by this paper
• The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

  2009cited by this paper
• Cancer testis antigens in human melanoma stem cells: Expression, distribution, and methylation status

  2008cited by this paper
• Differential presentation of tumor antigen‐derived epitopes by MHC‐class I and antigen‐positive tumor cells

  2008cited by this paper
• Faculty Opinions recommendation of The mouse X chromosome is enriched for multicopy testis genes showing postmeiotic expression.

  2008cited by this paper
• The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4

  2008cited by this paper
• Genetically appropriate expression of HLA and DR (IA) alloantigens on human melanoma cell lines.

  2008cited by this paper
• The mouse X chromosome is enriched for multi-copy testis genes exhibiting post-meiotic expression

  2008cited by this paper
• Identification of a common HLA-A*0201-restricted epitope among SSX family members by mimicking altered peptide ligands strategy.

  2008cited by this paper
• Assessment of CD4+  T cells specific for the tumor antigen SSX-1 in cancer-free individuals

  2007cited by this paper
• SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patients

  2007cited by this paper
• SSX2IP: an emerging role in cancer.

  2007cited by this paper
• The leukaemia‐associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells

  2007cited by this paper
• Potential target antigens for immunotherapy in human pancreatic cancer.

  2007cited by this paper
• Inducible expression of a prostate cancer‐testis antigen, SSX‐2, following treatment with a DNA methylation inhibitor

  2007cited by this paper
• Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients

  2006cited by this paper
• The testis in immune privilege

  2006cited by this paper
• Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer

  2006cited by this paper
• Expression of Synovial Sarcoma X (SSX) Antigens in Epithelial Ovarian Cancer and Identification of SSX-4 Epitopes Recognized by CD4+ T Cells

  2006cited by this paper
• Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.

  2005influential reference
• Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.

  2005influential reference
• The DNA sequence of the human X chromosome

  2005cited by this paper
• Cancer-testis antigen expression in bladder cancer.

  2005cited by this paper
• Cancer-testis antigen expression in bladder cancer.

  2005cited by this paper
• CD4+ T Cell Responses to SSX-4 in Melanoma Patients1

  2005cited by this paper
• Naturally Acquired MAGE-A10- and SSX-2-Specific CD8+ T Cell Responses in Patients with Hepatocellular Carcinoma1

  2005cited by this paper
• Distinct but overlapping T helper epitopes in the 37-58 region of SSX-2.

  2005cited by this paper
• CD4 T Cell Responses to SSX-4 in Melanoma Patients

  2005cited by this paper
• Expression Profile of Cancer-Testis Genes in 121 Human Colorectal Cancer Tissue and Adjacent Normal Tissue

  2005cited by this paper
• Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification.

  2005cited by this paper
• SSX Cancer Testis Antigens are Expressed in Most Multiple Myeloma Patients: Co-Expression of SSX1, 2, 4, and 5 Correlates With Adverse Prognosis and High Frequencies of SSX-Positive PCs

  2005cited by this paper
• Concluding Remarks and Future Directions

  2004cited by this paper
• Expression of cancer testis antigens in pancreatic carcinoma cell lines, pancreatic adenocarcinoma and chronic pancreatitis

  2004cited by this paper
• Identification of an HLA‐DR‐restricted peptide epitope with a promiscuous binding pattern derived from the cancer testis antigen HOM‐MEL‐40/SSX2

  2004cited by this paper
• [Expression of multiple cancer-testis antigen genes in non-small cell lung cancer treated by chemotherapy prior surgery].

  2004cited by this paper
• Identification of an SSX-2 Epitope Presented by Dendritic Cells to Circulating Autologous CD4+ T Cells1

  2004cited by this paper
• Expression of Cancer-Testis Antigen (CTA) Genes in Intrahepatic Cholangiocarcinoma

  2004cited by this paper
• Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine

  2004cited by this paper
• SSX expression in gynecological cancers and antibody response in patients.

  2004cited by this paper
• An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR.

  2004cited by this paper
• Aberrant expression of the LHX4 LIM‐homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis

  2003cited by this paper
• Identification of an HLA-A*02 restricted immunogenic peptide derived from the cancer testis antigen HOM-MEL-40/SSX2.

  2003cited by this paper
• SSX antigens as tumor vaccine targets in human sarcoma.

  2003cited by this paper
• Differential expression of cancer testis genes in histological subtypes of non-Hodgkin's lymphomas.

  2003cited by this paper
• Identification and characterization of mouse SSX genes: a multigene family on the X chromosome with restricted cancer/testis expression.

  2003cited by this paper
• Expression of serologically identified tumor antigens in acute leukemias.

  2003cited by this paper
• Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients.

  2003cited by this paper
• Cancer/testis‐associated genes: Identification, expression profile, and putative function

  2003cited by this paper
• Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.

  2003cited by this paper
• SYT Associates with Human SNF/SWI Complexes and the C-terminal Region of Its Fusion Partner SSX1 Targets Histones*

  2002cited by this paper
• The SSX gene family: Characterization of 9 complete genes

  2002influential reference
• Antigens derived from melanocyte differentiation proteins: self‐tolerance, autoimmunity, and use for cancer immunotherapy

  2002cited by this paper
• The cancer‐related protein SSX2 interacts with the human homologue of a Ras‐like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP

  2002cited by this paper
• Combinatorial peptide library‐based identification of peptide ligands for tumor‐reactive cytolytic T lymphocytes of unknown specificity

  2002cited by this paper
• A novel chromosomal translocation t(1;14)(q25;q32) in pre-B acute lymphoblastic leukemia involves the LIM homeodomain protein gene, Lhx4

  2002cited by this paper
• Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications

  2002cited by this paper
• Proteasome-Assisted Identification of a SSX-2-Derived Epitope Recognized by Tumor-Reactive CTL Infiltrating Metastatic Melanoma1

  2002cited by this paper
• Immunotherapeutic Targets Cancer : Identification of Potential Diagnostic and Cancer-related Serological Recognition of Human Colon Updated

  2002cited by this paper
• Expression of SSX genes in the neoplastic cells of Hodgkin's lymphoma.

  2002cited by this paper
• Expression of SSX-2 and SSX-4 genes in neuroblastoma.

  2002cited by this paper
• Expression of SSX genes in human osteosarcomas

  2002cited by this paper
• Combinatorial Peptide Libraries and Biometric Score Matrices Permit the Quantitative Analysis of Specific and Degenerate Interactions Between Clonotypic TCR and MHC Peptide Ligands1

  2001cited by this paper
• Molecular mechanisms underlying human synovial sarcoma development

  2001cited by this paper
• Expressions of cancer-testis antigens in human hepatocellular carcinomas.

  2001cited by this paper
• Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self

  2001cited by this paper
• Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

  2001cited by this paper
• Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization.

  2000cited by this paper
• Expression of cancer testis genes in human brain tumors.

  2000cited by this paper
• Association of SYT-SSX Fusion Types with Proliferative Activity and Prognosis in Synovial Sarcoma

  2000cited by this paper
• Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

  2000influential reference
• SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex

  1999cited by this paper
• SYFPEITHI: database for MHC ligands and peptide motifs

  1999cited by this paper
• Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

  1999cited by this paper
• Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene.

  1999cited by this paper
• The overlooked “nonclassical” functions of major histocompatibility complex (MHC) class II antigens in immune and nonimmune cells

  1999cited by this paper
• A novel fusion gene, SYT-SSX4, in synovial sarcoma.

  1999cited by this paper
• DNA copy number losses in human neoplasms.

  1999cited by this paper
• Cytogenetic analysis of 363 consecutively ascertained diffuse large B‐cell lymphomas

  1999cited by this paper
• Transcript mapping of the human chromosome 11q12-q13.1 gene-rich region identifies several newly described conserved genes.

  1998cited by this paper
• DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

  1998cited by this paper
• A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens

  1998cited by this paper
• A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas

  1998cited by this paper
• HER-2/neu oncogenic protein: issues in vaccine development.

  1998cited by this paper
• Expression of SSX genes in human tumors

  1998cited by this paper
• The Human Polycomb Group Complex Associates with Pericentromeric Heterochromatin to Form a Novel Nuclear Domain

  1998influential reference
• Polycombing the genome: PcG, trxG, and chromatin silencing.

  1998cited by this paper
• The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies.

  1997cited by this paper
• SSX: A multigene family with several members transcribed in normal testis and human cancer

  1997influential reference
• Altered DNA methylation and genome instability: a new pathway to cancer?

  1997cited by this paper
• Altered cellular proliferation and mesoderm patterning in Polycomb-M33-deficient mice.

  1997cited by this paper
• Nuclear localization of SYT, SSX and the synovial sarcoma-associated SYT-SSX fusion proteins.

  1997influential reference
• Cloning, Expression, and Chromosomal Localization to 11p12-13 of a Human LIM/HOMEOBOX Gene, hLim-1

  1997cited by this paper
• Murine Polycomb- and trithorax-group genes regulate homeotic pathways and beyond.

  1997cited by this paper
• Hypomethylation of human sperm pronuclear chromosomes.

  1997cited by this paper

• Research progress in enhancing the precision of TCR-T cell therapy targeting cancer-testis antigens for cancer treatment in elderly patients

  2026cites this paper
• Gene pseudogenization in fertility-associated genes in cheetah (Acinonyx jubatus), a species with long-term low effective population size.

  2025cites this paper
• Functional Classification of Fusion Proteins in Sarcoma

  2024cites this paper
• Molecular genetic characterization of myeloid neoplasms with idic(X)(q13) and i(X)(q10)

  2024cites this paper
• New approaches and prospects of immunotherapy and gene therapy for prostate cancer

  2024cites this paper
• Aberrant gene activation in synovial sarcoma relies on SSX specificity and increased PRC1.1 stability

  2023cites this paper
• Higher Expression Levels of SSX1 and SSX2 in Patients with Colon Cancer: Regulated In Vitro by the Inhibition of Methylation and Histone Deacetylation

  2023cites this paper
• SSX addiction in melanoma propagates tumor growth and metastasis

  2022cites this paper
• Nucleic acid vaccination strategies for ovarian cancer

  2022cites this paper
• The KRAB Domain of ZNF10 Guides the Identification of Specific Amino Acids That Transform the Ancestral KRAB-A-Related Domain Present in Human PRDM9 into a Canonical Modern KRAB-A Domain

  2022cites this paper
• Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients

  2022cites this paper
• Machine Learning and Systems Biology Approaches to Characterize Dosage-Based Gene Dependencies in Cancer Cells

  2021cites this paper
• Molecular Basis of Synovial Sarcoma and the Rare Case of its Localization in Palatine Tonsil: A Review of the Literature

  2021cites this paper
• Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemia

  2021influential citation
• Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion

  2021cites this paper
• Long-term expression changes of immune-related genes in prostate cancer after radiotherapy

  2021cites this paper
• CRTC1–SS18 Fusion Sarcoma With Aberrant Anaplastic Lymphoma Kinase Expression

  2021cites this paper
• Identification and Validation of the Prognostic Stemness Biomarkers in Bladder Cancer Bone Metastasis

  2021cites this paper
• Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma

  2021cites this paper
• The nucleosome acidic patch and H2A ubiquitination underlie mSWI/SNF recruitment in synovial sarcoma

  2020cites this paper
• T cell receptor therapy against melanoma—Immunotherapy for the future?

  2020cites this paper
• Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process

  2020cites this paper
• University of Southern Denmark Interaction between Polycomb and SSX Proteins in Pericentromeric Heterochromatin Function and Its Implication in Cancer Johansen, Simone; Gjerstorff,

  2020cites this paper
• An Introduction to CAR Immunotherapy

  2020cites this paper
• Photodynamic Therapy and Antitumor Immune Response

  2020cites this paper
• Immunopathology of Bone and Connective Tissue Cancers and Immunotherapy of Sarcomas

  2020cites this paper
• Synovial Sarcoma: A Complex Disease with Multifaceted Signaling and Epigenetic Landscapes

  2020cites this paper
• Critical testing and parameters for consideration when manufacturing and evaluating tumor-associated antigen-specific T cells.

  2019cites this paper
• Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells

  2019cites this paper
• Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins

  2019cites this paper
• Expression and prognostic utility of SSX2IP in patients with nasopharyngeal carcinoma

  2019cites this paper
• Novel Immunotherapeutic Agents for the Treatment of Multiple Myeloma

  2019cites this paper
• Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia

  2019cites this paper
• Opposing immune and genetic forces shape oncogenic programs in synovial sarcoma

  2019cites this paper
• DUX4 Suppresses MHC Class I to Promote Cancer Immune Evasion and Resistance to Checkpoint Blockade.

  2019cites this paper
• A Non-canonical Polycomb Dependency in Synovial Sarcoma.

  2018cites this paper
• Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.

  2018cites this paper
• Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood

  2018cites this paper
• Disruption of mammalian SWI/SNF and polycomb complexes in human sarcomas: mechanisms and therapeutic opportunities

  2018cites this paper
• Développement d'une stratégie de vaccination thérapeutique antitumorale basée sur l'utilisation de lipopolyplexes à ARN ciblant les cellules dendritiques

  2017cites this paper
• Melanoma antigens and related immunological markers.

  2017influential citation
• Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells

  2017cites this paper
• A De Novo Xp11.23 Duplication in a Girl with a Severe Phenotype: Expanding the Clinical Spectrum

  2017cites this paper
• Multicellular tumor spheroids of human uveal melanoma induce genes associated with anoikis resistance, lipogenesis, and SSXs

  2017cites this paper
• Current Strategies for the Immunotherapy of Multiple Myeloma.

  2017cites this paper
• Inducible expression of cancer-testis antigens in human prostate cancer

  2016cites this paper
• SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer

  2016cites this paper
• Cancer testis antigen OY-TES-1: analysis of protein expression in ovarian cancer with tissue microarrays.

  2015cites this paper
• T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?

  2015cites this paper
• Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer

  2015cites this paper
• PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope–Modified DNA Vaccine Immunization

  2015cites this paper
• Identification of novel tumour-associated antigens in canine mammary gland tumour.

  2015cites this paper
• Evaluation of melanoma antigen (MAGE) gene expression in human cancers using The Cancer Genome Atlas.

  2015cites this paper
• Photodynamic Therapy and Antitumor Immune Response

  2015cites this paper
• Expression of cancer-testis antigen in multiple myeloma

  2014cites this paper
• Expression of cancer-testis antigens MAGEA1, MAGEA3, ACRBP, PRAME, SSX2, and CTAG2 in myxoid and round cell liposarcoma

  2014cites this paper
• Evolving role of tumor antigens for future melanoma therapies.

  2014cites this paper
• SSX2-4 expression in early-stage non-small cell lung cancer.

  2014cites this paper
• Adoptive immunotherapy for cancer

  2014cites this paper
• Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC

  2014cites this paper
• Specific active immunotherapy with a VEGF vaccine in patients with advanced solid tumors. results of the CENTAURO antigen dose escalation phase I clinical trial.

  2014cites this paper
• Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma.

  2014cites this paper
• DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses.

  2014cites this paper
• Expression of NY-ESO-1 in Primary and Metastatic Melanoma

  2014cites this paper
• Identification and functional characterisation of potential novel cancer-testis genes in human cancer cells

  2014cites this paper
• Expression of SSX-1 and SSX-5 genes in the peripheral blood of patients with hepatocellular carcinoma

  2014cites this paper
• Melanoma Antigens and Immunological Markers

  2014cites this paper
• Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

  2014cites this paper
• Molekulargenetische Charakterisierung pädiatrischer T-Zell lymphoblastischer Lymphome unter Herstellung von Genexpressionsprofilen

  2014cites this paper
• Molecular Testing in Bone and Soft Tissue Tumors

  2014cites this paper
• Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A.

  2013cites this paper
• Expression of cancer-testis antigen in multiple myeloma

  2013cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2013cites this paper
• Improving the efficacy and safety of engineered T cell therapy for cancer.

  2013cites this paper
• Therapeutics , Targets , and Chemical Biology Photodynamic Therapy of Murine Mastocytoma Induces Speci fi c Immune Responses against the Cancer / Testis Antigen P 1 A

  2013cites this paper
• Meiotic recombination in mammals: localization and regulation

  2013cites this paper
• Gene expression profiling of thymus in beef cattle treated with prednisolone.

  2013cites this paper
• New targets for the immunotherapy of colon cancer—does reactive disease hold the answer?

  2013cites this paper
• Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma.

  2013cites this paper
• Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein

  2013cites this paper
• Rational combinations of immunotherapeutics that target discrete pathways

  2013cites this paper
• Genetically Modified T Cells for the Treatment of Malignant Disease

  2013cites this paper
• Subnuclear distribution of SSX regulates its function

  2013cites this paper
• Knockdown of OY‐TES‐1 by RNAi causes cell cycle arrest and migration decrease in bone marrow‐derived mesenchymal stem cells

  2012cites this paper
• Vaccination using peptides spanning the SYT–SSX tumor-specific translocation

  2012cites this paper
• Cancer/testis antigen SSX2 enhances invasiveness in MCF-7 cells by repressing ERα signaling.

  2012cites this paper
• Tumor-Associated Antigens for Specific Immunotherapy of Prostate Cancer

  2012cites this paper
• Cross-Analysis of Gene and miRNA Genome-Wide Expression Profiles in Human Fibroblasts at Different Stages of Transformation

  2012cites this paper
• Développement d'une immunothérapie spécifique contre le cancer de la vessie : caractérisation de l'immunogénicité de l'antigène tumoral MAGE-A9

  2012cites this paper
• Cancer/testis (CT) antigens, carcinogenesis and spermatogenesis

  2011cites this paper
• Expression Patterns of Cancer-Testis Antigens in Human Embryonic Stem Cells and Their Cell Derivatives Indicate Lineage Tracks

  2011cites this paper
• Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer.

  2011cites this paper